Lantern Pharma Inc. Share Price
NASDAQ: LTRN | Micro CapLantern Pharma Inc. Stock Performance
Lantern Pharma Inc. Share Price Today
As of 30 October 2026, Lantern Pharma Inc.'s share price is $0.68. The stock opened at $0.71, compared to its previous close of $0.75. During today's trading session, Lantern Pharma Inc.'s share price traded between $0.68 and $0.71, with an average price of $0.69. Over the past 52 weeks, the stock has recorded a high of $4.29 and a low of $0.60. In terms of performance, Lantern Pharma Inc.'s share price has declined by 67.36% over the last six months and is down 83.11% on a year-on-year basis.
Lantern Pharma Inc. Share Price Chart
Lantern Pharma Inc. Quarterly Profit & Loss
All figures in USD
Lantern Pharma Inc. Annual Profit & Loss
All figures in USD
About Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Lantern Pharma Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.99 | $0.68 | -32.07% |
Sep 2026 | $2.04 | $1.00 | -53.63% |
Aug 2026 | $2.71 | $2.17 | -17.05% |
Jul 2026 | $4.13 | $2.61 | -37.86% |
Jun 2026 | $3.48 | $4.20 | +19.49% |
May 2026 | $1.99 | $3.52 | +68.18% |
Apr 2026 | $1.52 | $2.09 | +54.24% |
Mar 2026 | $2.73 | $1.35 | -51.61% |
Feb 2026 | $3.11 | $2.80 | -9.68% |
Jan 2026 | $3.01 | $3.10 | +2.31% |
Dec 2025 | $3.61 | $3.03 | -20.47% |
Nov 2025 | $3.96 | $3.81 | -5.69% |